no code implementations • 21 Mar 2022 • K. López-de-Ipiña, Marcos Faundez-Zanuy, Jordi Solé-Casals, Fernando Zelarin, Pilar Calvo
Most of medical developments require the ability to identify samples that are anomalous with respect to a target group or control group, in the sense they could belong to a new, previously unseen class or are not class data.